West Pharmaceutical Services Research and Development Expenses 2010-2024 | WST

West Pharmaceutical Services annual/quarterly research and development expenses history and growth rate from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • West Pharmaceutical Services research and development expenses for the quarter ending September 30, 2024 were $0.016B, a 5.49% decline year-over-year.
  • West Pharmaceutical Services research and development expenses for the twelve months ending September 30, 2024 were $69M, a 4.7% increase year-over-year.
  • West Pharmaceutical Services annual research and development expenses for 2023 were $0.068B, a 16.92% increase from 2022.
  • West Pharmaceutical Services annual research and development expenses for 2022 were $0.059B, a 10.8% increase from 2021.
  • West Pharmaceutical Services annual research and development expenses for 2021 were $0.053B, a 12.58% increase from 2020.
West Pharmaceutical Services Annual Research and Development Expenses
(Millions of US $)
2023 $68
2022 $59
2021 $53
2020 $47
2019 $39
2018 $40
2017 $39
2016 $37
2015 $34
2014 $37
2013 $38
2012 $33
2011 $29
2010 $24
2009 $20
West Pharmaceutical Services Quarterly Research and Development Expenses
(Millions of US $)
2024-09-30 $16
2024-06-30 $18
2024-03-31 $18
2023-12-31 $18
2023-09-30 $16
2023-06-30 $17
2023-03-31 $17
2022-12-31 $16
2022-09-30 $14
2022-06-30 $14
2022-03-31 $15
2021-12-31 $14
2021-09-30 $13
2021-06-30 $14
2021-03-31 $12
2020-12-31 $13
2020-09-30 $13
2020-06-30 $11
2020-03-31 $11
2019-12-31 $10
2019-09-30 $9
2019-06-30 $10
2019-03-31 $10
2018-12-31 $10
2018-09-30 $10
2018-06-30 $11
2018-03-31 $10
2017-12-31 $10
2017-09-30 $9
2017-06-30 $10
2017-03-31 $10
2016-12-31 $10
2016-09-30 $9
2016-06-30 $9
2016-03-31 $9
2015-12-31 $10
2015-09-30 $9
2015-06-30 $8
2015-03-31 $8
2014-12-31 $8
2014-09-30 $10
2014-06-30 $10
2014-03-31 $10
2013-12-31 $10
2013-09-30 $10
2013-06-30 $10
2013-03-31 $9
2012-12-31 $9
2012-09-30 $8
2012-06-30 $8
2012-03-31 $8
2011-12-31 $7
2011-09-30 $8
2011-06-30 $7
2011-03-31 $7
2010-12-31 $7
2010-09-30 $6
2010-06-30 $6
2010-03-31 $5
2009-12-31 $6
2009-09-30 $5
2009-06-30 $5
2009-03-31 $4
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.472B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.492B 21.23
Becton Dickinson (BDX) United States $66.954B 17.60
Cardinal Health (CAH) United States $29.177B 15.82
Cooper (COO) United States $20.662B 29.41
Labcorp (LH) United States $20.273B 16.81
Align Technology (ALGN) United States $16.462B 31.50
Henry Schein (HSIC) United States $8.478B 16.15
Merit Medical Systems (MMSI) United States $5.988B 30.58
DENTSPLY SIRONA (XRAY) United States $3.620B 9.65
CONMED (CNMD) United States $2.268B 18.93
Patterson (PDCO) United States $1.833B 9.67
STAAR Surgical (STAA) United States $1.458B 53.80
Lifevantage (LFVN) United States $0.171B 22.77
Pro-Dex (PDEX) United States $0.139B 27.71